Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
PUT
ProShares Short Russell2000
RWM
$104M
| $2.46M | ﹤0.01% |
45,700
+900
| +2% | +$49.8K |
|
3202
Applied Industrial Technologies
AIT
$11.8B
| $2.46M | ﹤0.01% |
52,519
| – | – |
|
3203
CALL
Piper Sandler
PIPR
$5.34B
| $2.45M | ﹤0.01% |
+203,200
| New | +$2.21M |
|
|
CBM
3204
PUT
DELISTED
Cambrex Corporation
CBM
| $2.45M | ﹤0.01% |
55,200
-36,800
| -40% | -$1.79M |
|
|
JMBA
3205
PUT
DELISTED
Jamba, Inc.
JMBA
| $2.45M | ﹤0.01% |
224,500
-1,200
| -0.5% | -$12.9K |
|
3206
Caterpillar
CAT
$368B
| $2.45M | ﹤0.01% |
27,610
+21,799
| +375% | +$1.78M |
|
3207
PUT
Everest Group
EG
$14.5B
| $2.45M | ﹤0.01% |
12,900
-10,300
| -44% | -$1.94M |
|
3208
CALL
MarketAxess Holdings
MKTX
$5.73B
| $2.45M | ﹤0.01% |
14,800
+11,700
| +377% | +$1.9M |
|
|
HCRF
3209
DELISTED
iShares Edge MSCI Multifactor Healthcare ETF
HCRF
| $2.45M | ﹤0.01% |
92,117
-6,068
| -6% | -$162K |
|
3210
PUT
Omnicom Group
OMC
$24.2B
| $2.45M | ﹤0.01% |
28,800
-46,500
| -62% | -$3.9M |
|
3211
iShares US Pharmaceuticals ETF
IHE
$1.69B
| $2.44M | ﹤0.01% |
49,053
+15,687
| +47% | +$796K |
|
|
BEAT
3212
PUT
DELISTED
BioTelemetry, Inc.
BEAT
| $2.44M | ﹤0.01% |
131,500
+25,700
| +24% | +$485K |
|
3213
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.6B
| $2.44M | ﹤0.01% |
88,989
+10,569
| +13% | +$288K |
|
3214
PUT
PTC Therapeutics
PTCT
$5.85B
| $2.44M | ﹤0.01% |
173,900
+17,500
| +11% | +$142K |
|
3215
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.96B
| $2.44M | ﹤0.01% |
41,770
+3,427
| +9% | +$198K |
|
3216
ONE Gas
OGS
$5B
| $2.44M | ﹤0.01% |
39,374
-5,979
| -13% | -$379K |
|
|
PTLA
3217
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.44M | ﹤0.01% |
107,200
-43,500
| -29% | -$1.02M |
|
|
BATS
3218
PUT
DELISTED
Bats Global Markets, Inc.
BATS
| $2.44M | ﹤0.01% |
80,800
+64,300
| +390% | +$1.65M |
|
3219
PTC
PTC
$17.1B
| $2.43M | ﹤0.01% |
54,912
+42,654
| +348% | +$1.77M |
|
3220
CALL
Manhattan Associates
MANH
$13B
| $2.43M | ﹤0.01% |
42,200
-132,200
| -76% | -$7.96M |
|
|
BOBE
3221
CALL
DELISTED
Bob Evans Farms, Inc.
BOBE
| $2.43M | ﹤0.01% |
63,400
-5,900
| -9% | -$222K |
|
3222
iShares Asia 50 ETF
AIA
$5.16B
| $2.43M | ﹤0.01% |
48,443
-72,419
| -60% | -$3.47M |
|
3223
CALL
Ametek
AME
$54.2B
| $2.43M | ﹤0.01% |
50,800
-24,900
| -33% | -$1.19M |
|
|
LLTC
3224
CALL
DELISTED
Linear Technology Corp
LLTC
| $2.42M | ﹤0.01% |
40,900
-292,800
| -88% | -$16.4M |
|
|
AMRN
3225
PUT
Amarin Corp
AMRN
$295M
| $2.42M | ﹤0.01% |
37,960
+14,645
| +63% | +$821K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.